Patient‐reported outcomes in moderate‐to‐severe plaque psoriasis with scalp involvement: results from a randomized, double‐blind, placebo‐controlled study of etanercept
Authors:
- 21 December 2011
- journal article
- letter
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 27 (1) , 125-128
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Moderate to severe plaque psoriasis with scalp involvement: A randomized, double-blind, placebo-controlled study of etanerceptJournal of the American Academy of Dermatology, 2012
- Factors affecting sleep quality in patients with psoriasisJournal of the American Academy of Dermatology, 2010
- Treatment of severe scalp psoriasis: From the Medical Board of the National Psoriasis FoundationJournal of the American Academy of Dermatology, 2009
- Scalp psoriasis: a review of current topical treatment optionsJournal of the European Academy of Dermatology and Venereology, 2007
- Long-term Safety and Efficacy of 50 mg of Etanercept Twice Weekly in Patients With PsoriasisArchives of Dermatology, 2007
- Psoriasis Is Common, Carries a Substantial Burden Even When Not Extensive, and Is Associated with Widespread Treatment DissatisfactionJournal of Investigative Dermatology Symposium Proceedings, 2004